Clinical Trial: META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07689604) titled 'META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia' on June 29.

Brief Summary: A Study of Metabolically Armed Autologous CD19 CAR T-Cell Therapy (META 10-19) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia

Study Start Date: July 08

Study Type: INTERVENTIONAL

Condition: Autoimmune Hemolytic Anemia (AIHA)

Intervention: BIOLOGICAL: Metabolically Armed Autologous CD19 CAR T-Cell therapy

Metabolically Armed Autologous CD19 CAR T-cells. Each subject receive metabolically autologous armed CD19 CAR T-cells by intravenous infusion.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Institute of ...